These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11380621)

  • 1. Crk family adaptor proteins trans-activate c-Abl kinase.
    Shishido T; Akagi T; Chalmers A; Maeda M; Terada T; Georgescu MM; Hanafusa H
    Genes Cells; 2001 May; 6(5):431-40. PubMed ID: 11380621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Abl kinase regulates the protein binding activity of c-Crk.
    Feller SM; Knudsen B; Hanafusa H
    EMBO J; 1994 May; 13(10):2341-51. PubMed ID: 8194526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
    Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
    Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites.
    Ren R; Ye ZS; Baltimore D
    Genes Dev; 1994 Apr; 8(7):783-95. PubMed ID: 7926767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The product of the cbl oncogene forms stable complexes in vivo with endogenous Crk in a tyrosine phosphorylation-dependent manner.
    Ribon V; Hubbell S; Herrera R; Saltiel AR
    Mol Cell Biol; 1996 Jan; 16(1):45-52. PubMed ID: 8524328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
    Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
    Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct binding of C-terminal region of p130Cas to SH2 and SH3 domains of Src kinase.
    Nakamoto T; Sakai R; Ozawa K; Yazaki Y; Hirai H
    J Biol Chem; 1996 Apr; 271(15):8959-65. PubMed ID: 8621540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of Crk on tyrosine 251 in the RT loop of the SH3C domain promotes Abl kinase transactivation.
    Sriram G; Reichman C; Tunceroglu A; Kaushal N; Saleh T; Machida K; Mayer B; Ge Q; Li J; Hornbeck P; Kalodimos CG; Birge RB
    Oncogene; 2011 Nov; 30(46):4645-55. PubMed ID: 21602891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 31-amino-acid N-terminal extension regulates c-Crk binding to tyrosine-phosphorylated proteins.
    Fajardo JE; Birge RB; Hanafusa H
    Mol Cell Biol; 1993 Dec; 13(12):7295-302. PubMed ID: 7504172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. v-Crk activates the phosphoinositide 3-kinase/AKT pathway by utilizing focal adhesion kinase and H-Ras.
    Akagi T; Murata K; Shishido T; Hanafusa H
    Mol Cell Biol; 2002 Oct; 22(20):7015-23. PubMed ID: 12242282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of c-Crk II on the negative regulatory Tyr222 mediates nerve growth factor-induced cell spreading and morphogenesis.
    Escalante M; Courtney J; Chin WG; Teng KK; Kim JI; Fajardo JE; Mayer BJ; Hempstead BL; Birge RB
    J Biol Chem; 2000 Aug; 275(32):24787-97. PubMed ID: 10825157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases.
    Mayer BJ; Hirai H; Sakai R
    Curr Biol; 1995 Mar; 5(3):296-305. PubMed ID: 7780740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide.
    Donaldson LW; Gish G; Pawson T; Kay LE; Forman-Kay JD
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14053-8. PubMed ID: 12384576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins.
    Tanaka M; Gupta R; Mayer BJ
    Mol Cell Biol; 1995 Dec; 15(12):6829-37. PubMed ID: 8524249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine-phosphorylated epidermal growth factor receptor and cellular p130 provide high affinity binding substrates to analyze Crk-phosphotyrosine-dependent interactions in vitro.
    Birge RB; Fajardo JE; Mayer BJ; Hanafusa H
    J Biol Chem; 1992 May; 267(15):10588-95. PubMed ID: 1375224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crk-associated substrate tyrosine phosphorylation sites are critical for invasion and metastasis of SRC-transformed cells.
    Brábek J; Constancio SS; Siesser PF; Shin NY; Pozzi A; Hanks SK
    Mol Cancer Res; 2005 Jun; 3(6):307-15. PubMed ID: 15972849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of c-Src in cells bearing v-Crk and its suppression by Csk.
    Sabe H; Okada M; Nakagawa H; Hanafusa H
    Mol Cell Biol; 1992 Oct; 12(10):4706-13. PubMed ID: 1383688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iterative tyrosine phosphorylation controls non-canonical domain utilization in Crk.
    Sriram G; Jankowski W; Kasikara C; Reichman C; Saleh T; Nguyen KQ; Li J; Hornbeck P; Machida K; Liu T; Li H; Kalodimos CG; Birge RB
    Oncogene; 2015 Aug; 34(32):4260-9. PubMed ID: 25381819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SH3 domain of Crk binds specifically to a conserved proline-rich motif in Eps15 and Eps15R.
    Schumacher C; Knudsen BS; Ohuchi T; Di Fiore PP; Glassman RH; Hanafusa H
    J Biol Chem; 1995 Jun; 270(25):15341-7. PubMed ID: 7797522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK.
    Jung JH; Pendergast AM; Zipfel PA; Traugh JA
    Biochemistry; 2008 Jan; 47(3):1094-104. PubMed ID: 18161990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.